EP2775835A4 - Procédés permettant de traiter la goutte chez des groupes de patients - Google Patents
Procédés permettant de traiter la goutte chez des groupes de patientsInfo
- Publication number
- EP2775835A4 EP2775835A4 EP11875027.2A EP11875027A EP2775835A4 EP 2775835 A4 EP2775835 A4 EP 2775835A4 EP 11875027 A EP11875027 A EP 11875027A EP 2775835 A4 EP2775835 A4 EP 2775835A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- methods
- treating gout
- patient subpopulations
- subpopulations
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2011/059425 WO2013066352A1 (fr) | 2011-11-04 | 2011-11-04 | Procédés permettant de traiter la goutte chez des groupes de patients |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2775835A1 EP2775835A1 (fr) | 2014-09-17 |
EP2775835A4 true EP2775835A4 (fr) | 2015-07-29 |
Family
ID=48192536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11875027.2A Withdrawn EP2775835A4 (fr) | 2011-11-04 | 2011-11-04 | Procédés permettant de traiter la goutte chez des groupes de patients |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP2775835A4 (fr) |
JP (1) | JP6047172B2 (fr) |
KR (1) | KR101848122B1 (fr) |
CN (1) | CN104066323A (fr) |
AU (1) | AU2011380509B2 (fr) |
BR (1) | BR112014010693A2 (fr) |
CA (1) | CA2859689C (fr) |
CL (1) | CL2014001156A1 (fr) |
IL (1) | IL232385A (fr) |
MX (1) | MX354846B (fr) |
NZ (1) | NZ624714A (fr) |
SG (1) | SG11201402027PA (fr) |
WO (1) | WO2013066352A1 (fr) |
ZA (1) | ZA201403574B (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2013245675B2 (en) * | 2012-04-13 | 2017-02-09 | Cymabay Therapeutics, Inc. | Method for treating hyperuricemia in patients with gout using halofenate or halofenic acid and an anti-inflammatory agent |
CN105851522A (zh) * | 2014-07-25 | 2016-08-17 | 许伟琦 | 一种防止尿路结石的饲料 |
CN105920022A (zh) * | 2016-05-12 | 2016-09-07 | 成都易创思生物科技有限公司 | 一种抗痛风药物复方制剂 |
WO2019082335A1 (fr) * | 2017-10-26 | 2019-05-02 | 大塚製薬株式会社 | Composition contenant du phosphate d'inositol |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4250191A (en) * | 1978-11-30 | 1981-02-10 | Edwards K David | Preventing renal failure |
US6262118B1 (en) * | 1999-06-04 | 2001-07-17 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ME01294B (fr) * | 2007-11-27 | 2013-06-20 | Ardea Biosciences Inc | Nouveaux composés et nouvelles compositions et leurs procédés d'utilisation |
-
2011
- 2011-11-04 EP EP11875027.2A patent/EP2775835A4/fr not_active Withdrawn
- 2011-11-04 BR BR112014010693-2A patent/BR112014010693A2/pt not_active IP Right Cessation
- 2011-11-04 CA CA2859689A patent/CA2859689C/fr not_active Expired - Fee Related
- 2011-11-04 KR KR1020147015209A patent/KR101848122B1/ko active IP Right Grant
- 2011-11-04 AU AU2011380509A patent/AU2011380509B2/en not_active Ceased
- 2011-11-04 JP JP2014541012A patent/JP6047172B2/ja not_active Expired - Fee Related
- 2011-11-04 CN CN201180076189.7A patent/CN104066323A/zh active Pending
- 2011-11-04 SG SG11201402027PA patent/SG11201402027PA/en unknown
- 2011-11-04 WO PCT/US2011/059425 patent/WO2013066352A1/fr active Application Filing
- 2011-11-04 MX MX2014005399A patent/MX354846B/es active IP Right Grant
- 2011-11-04 NZ NZ624714A patent/NZ624714A/en not_active IP Right Cessation
-
2014
- 2014-04-30 IL IL232385A patent/IL232385A/en active IP Right Grant
- 2014-05-02 CL CL2014001156A patent/CL2014001156A1/es unknown
- 2014-05-16 ZA ZA2014/03574A patent/ZA201403574B/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4250191A (en) * | 1978-11-30 | 1981-02-10 | Edwards K David | Preventing renal failure |
US6262118B1 (en) * | 1999-06-04 | 2001-07-17 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
US6613802B1 (en) * | 1999-06-04 | 2003-09-02 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
Non-Patent Citations (7)
Title |
---|
ANONYMOUS: "Metabolex Appoints Raymond Urbanski M.D., Ph.D. to Position of Chief Medical Officer", 20 October 2011 (2011-10-20), XP002740530, Retrieved from the Internet <URL:http://www.fiercebiotech.com> [retrieved on 20150603] * |
ANONYMOUS: "Metabolex Initiates Phase 2 Trial of Arhalofenate", 19 May 2011 (2011-05-19), XP002740529, Retrieved from the Internet <URL:http://www.prnewswire.com/news-releases> [retrieved on 20150603] * |
EDWARDS K D G ET AL: "AMINO NUCLEOSIDE INDUCED CHRONIC RENAL FAILURE IN RATS ENHANCEMENT BY DIETARY HYPER LIPIDEMIAS AND PROTECTION BY A HYPO LIPIDEMIC DIET OR HALOFENATE", KIDNEY INTERNATIONAL, vol. 14, no. 6, 1978, pages 723, XP002740532, ISSN: 0085-2538 * |
EDWARDS K D G ET AL: "PROTECTION BY L TRYPTOPHAN OR HALOFENATE AGAINST HYPER LIPIDEMIA AND ACUTE OR CHRONIC AMINO NUCLEOSIDE NEPHROSIS IN SUCROSE LARD FED RATS", KIDNEY INTERNATIONAL, vol. 12, no. 6, 1977, pages 480, XP002740533, ISSN: 0085-2538 * |
EL-ZAWAWY HOSSAM ET AL: "Managing gout: How is it different in patients with chronic kidney disease?", CLEVELAND CLINIC JOURNAL OF MEDICINE, vol. 77, no. 12, December 2010 (2010-12-01), pages 919 - 928, XP002740531 * |
MAHESH J FULDEORE ET AL: "Chronic kidney disease in gout in a managed care setting", BMC NEPHROLOGY, BIOMED CENTRAL, LONDON, GB, vol. 12, no. 1, 3 August 2011 (2011-08-03), pages 36, XP021108842, ISSN: 1471-2369, DOI: 10.1186/1471-2369-12-36 * |
See also references of WO2013066352A1 * |
Also Published As
Publication number | Publication date |
---|---|
MX2014005399A (es) | 2015-04-08 |
ZA201403574B (en) | 2015-11-25 |
AU2011380509A1 (en) | 2014-05-29 |
MX354846B (es) | 2018-03-22 |
CA2859689A1 (fr) | 2013-05-10 |
NZ624714A (en) | 2016-01-29 |
SG11201402027PA (en) | 2014-09-26 |
IL232385A0 (en) | 2014-06-30 |
CN104066323A (zh) | 2014-09-24 |
IL232385A (en) | 2017-10-31 |
BR112014010693A2 (pt) | 2020-11-10 |
CA2859689C (fr) | 2018-05-22 |
WO2013066352A1 (fr) | 2013-05-10 |
EP2775835A1 (fr) | 2014-09-17 |
JP6047172B2 (ja) | 2016-12-21 |
KR20140123927A (ko) | 2014-10-23 |
KR101848122B1 (ko) | 2018-04-11 |
AU2011380509B2 (en) | 2016-05-19 |
CL2014001156A1 (es) | 2015-01-16 |
JP2014532759A (ja) | 2014-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUE045988T2 (hu) | Csúsztatható berendezés hõterápiás kezeléshez | |
EP2671086A4 (fr) | Système et méthode de diagnostic et de traitement | |
LT3412687T (lt) | Didžiųjų b ląstelių difuzinės limfomos gydymo būdai | |
EP2531625A4 (fr) | Procédé de traitement des rejets | |
ZA201208219B (en) | Method for treating wasterwater | |
IL220594A0 (en) | Treatment method | |
EP2631461A4 (fr) | Procédé de traitement d'aimantation de carburant | |
LT2735250T (lt) | Slankiojančio tipo aparatas, skirtas termoterapiniam gydymui | |
SG11201401981TA (en) | Methods for treating gout flares | |
ZA201403574B (en) | Methods for treating gout in patient subpopulations | |
EP2536282A4 (fr) | Procédés pour traiter l'infection | |
GB201105523D0 (en) | Treatment method | |
EP2704731A4 (fr) | Traitement d'origine aviaire | |
EP2813798A4 (fr) | Procédé de traitement par explosion | |
EP2768536A4 (fr) | Méthode de traitement des diabètes de type i et de type ii | |
SG11201403180YA (en) | Improvements in machining apparatus | |
GB201109796D0 (en) | Treatment device | |
GB201102272D0 (en) | Treatment | |
GB201102266D0 (en) | Treatment | |
GB201102273D0 (en) | Treatment | |
GB201102274D0 (en) | Treatment | |
GB201102268D0 (en) | Treatment | |
GB201102269D0 (en) | Treatment | |
GB201102270D0 (en) | Treatment | |
GB201102271D0 (en) | Treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20140522 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A01N 37/00 20060101ALI20150609BHEP Ipc: A61P 19/06 20060101ALI20150609BHEP Ipc: A61K 31/20 20060101AFI20150609BHEP |
|
RA4 | Supplementary search report drawn up and despatched (corrected) |
Effective date: 20150626 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: CYMABAY THERAPEUTICS, INC. |
|
17Q | First examination report despatched |
Effective date: 20170331 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: CYMABAY THERAPEUTICS, INC. |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: DIATEX, INC. Owner name: CYMABAY THERAPEUTICS, INC. |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20190205 |